[HTML][HTML] Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their …

G Qi, X Zhang, X Gai, X Yan - PeerJ, 2024 - peerj.com
Objective To explore the relationship between receptor heterogeneity and
clinicopathological characteristics in 166 patients with invasive breast cancer during …

Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical …

G Qi, X Zhang, X Gai, X Yan - PeerJ, 2024 - pubmed.ncbi.nlm.nih.gov
Objective To explore the relationship between receptor heterogeneity and
clinicopathological characteristics in 166 patients with invasive breast cancer during …

Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical …

G Qi, X Zhang, X Gai, X Yan - Peerj, 2024 - europepmc.org
Objective To explore the relationship between receptor heterogeneity and
clinicopathological characteristics in 166 patients with invasive breast cancer during …

[HTML][HTML] Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their …

G Qi, X Zhang, X Gai, X Yan - PeerJ, 2024 - ncbi.nlm.nih.gov
Objective To explore the relationship between receptor heterogeneity and
clinicopathological characteristics in 166 patients with invasive breast cancer during …

Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical …

G Qi, X Zhang, X Gai, X Yan - PeerJ, 2024 - search.ebscohost.com
Objective: To explore the relationship between receptor heterogeneity and
clinicopathological characteristics in 166 patients with invasive breast cancer during …